Skip to main content

Table 1 Characteristics of studies contained in the meta-analyses

From: Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis

Study, year

Country

Number[Male/Female, mean age(years)]

Study design

Categories of NAFLD [Male/Female]

Definition

Additional information

NOS(0–9)

case

Control

NAFL(number)

NASH(number)

Natasha Chandok, 2011

Canada

88

NA

prospective study

60 (37/23)

28 (13/15)

liver biopsy

NA

6

Kikuko Hotta, 2010

Japan

253 (122/131,51)

578 (182/396,47)

case-control

64 (23/41,51)

189 (99/90,51)

liver biopsy.

NA

6

T-J Hsiao, 2004

Taiwan, China

43 (20/23,33)

167 (27/140,36)

case-control

NA

NA

Ultrasonography

obese

7

George BB Goh 2015

USA

405 (179/226,48)

NA

prospective study

114 (52/62,46)

291 (127/164,49)

liver biopsy.

NA

6

Michelino Di Rosa, 2013

Italy

200 (92/108)

100 (48/52,54.2)

case–control

90 (43/47,49)

110 (49/61,53)

Liver biopsy

NA

7

Ali Sazci,2008

Turkish

57 (31/26,44)

245 (106/139,45)

Case-control

NA

57 (31/26,44)

liver biopsy

NA

6

Youzhao Jiang, 2014

China

446 (351/95,46)

531 (201/330,42)

cross-sectional

NA

NA

liver biopsy.

NA

6

Hiroyuki Tsuchiya,2010

Japan

28

8 (30)

Case-control

17 (46)

11 (50)

liver biopsy

NA

6

Masato Yoneda, 2010

Japan

86

20

Case-control

24 (48)

62 (52)

liver biopsy.

NA

5

Zeljko Puljiz, 2010

Croatia

50 (32/18,43)

NA

prospective study

35

15

liver biopsy.

NA

5

B.Canbakan, 2007

US

105 (54/51)

NA

prospective study

38 (17/21)

67 (37/30)

liver biopsy

NA

4

DemircioÄŸlu F,2014

Turkey

30 (19/11,12)

50(17/33,12)

case–control

NA

NA

ultrasonography

obese

6

Nobili V, 2013

Italy

100 (68/32,11)

NA

case–control

70 (51/19,11)

30 (17/13,11)

liver biopsy.

NA

5

Alkhouri N, 2015

USA

117 (78/39,12)

NA

case–control

49 (30/19,12)

68 (48/20,13)

liver biopsy.

NA

5

  1. NAFL non-alcoholic fatty liver, NASH non-alcoholic steatohepatitis, NA not available